Sat Nov 23 15:40:00 UTC 2024: ## Scottish Study Shows Near-Total Effectiveness of HPV Vaccine in Preventing Cervical Cancer
**Glasgow, Scotland – November 23, 2024** – A groundbreaking study published in the *Journal of the National Cancer Institute* reveals the remarkable effectiveness of the HPV vaccine in preventing cervical cancer. Researchers in Scotland found zero cases of cervical cancer among women fully vaccinated at ages 12-13 as part of a program initiated in 2008. Even in a catch-up program vaccinating older teens (14-22), the vaccine significantly reduced cervical cancer incidence by 96.8%.
The bivalent vaccine targets HPV 16 and 18, responsible for approximately 70% of cervical cancers globally. While the study demonstrated exceptional protection, researchers emphasize that despite the vaccine’s effectiveness, cervical cancer screening remains crucial for all women, even those vaccinated. This is because the vaccine doesn’t protect against all HPV types, and a small number of cancers linked to other HPV strains may still occur. The study also highlighted the importance of early vaccination before sexual activity for optimal effectiveness.
The Scottish study also revealed a correlation between socioeconomic status and cervical cancer incidence, with higher rates among the most deprived populations. This underscores the need for equitable access to both vaccination and screening programs.
While the findings offer hope for global cervical cancer prevention, the researchers stress the importance of continued screening even in vaccinated individuals and advocate for wider implementation of vaccination programs worldwide, particularly in countries like India where cervical cancer screening rates are low. The need for increased screening in conjunction with vaccination is crucial for achieving the most significant impact in reducing the global burden of cervical cancer.
First Piper 